154 related articles for article (PubMed ID: 17463463)
1. Dipyridamole with aspirin is better than aspirin alone in preventing vascular events after ischaemic stroke or TIA.
Sudlow C
BMJ; 2007 Apr; 334(7599):901. PubMed ID: 17463463
[No Abstract] [Full Text] [Related]
2. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
3. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
Rouhl RP; Lodder J
Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236
[TBL] [Abstract][Full Text] [Related]
4. [Secondary prevention after stroke. Doubled performs better].
MMW Fortschr Med; 2003 Nov; 145(46):49. PubMed ID: 14699837
[No Abstract] [Full Text] [Related]
5. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
Greenhalgh J; Bagust A; Boland A; Martin Saborido C; Oyee J; Blundell M; Dundar Y; Dickson R; Proudlove C; Fisher M
Health Technol Assess; 2011 Sep; 15(31):1-178. PubMed ID: 21888837
[TBL] [Abstract][Full Text] [Related]
6. Cardiac safety in the European Stroke Prevention Study 2 (ESPS2).
Diener HC; Darius H; Bertrand-Hardy JM; Humphreys M;
Int J Clin Pract; 2001 Apr; 55(3):162-3. PubMed ID: 11351768
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
8. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
9. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.
Rothwell PM; Algra A; Chen Z; Diener HC; Norrving B; Mehta Z
Lancet; 2016 Jul; 388(10042):365-375. PubMed ID: 27209146
[TBL] [Abstract][Full Text] [Related]
10. Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline.
Prasad K; Siemieniuk R; Hao Q; Guyatt G; O'Donnell M; Lytvyn L; Heen AF; Agoritsas T; Vandvik PO; Gorthi SP; Fisch L; Jusufovic M; Muller J; Booth B; Horton E; Fraiz A; Siemieniuk J; Fobuzi AC; Katragunta N; Rochwerg B
BMJ; 2018 Dec; 363():k5130. PubMed ID: 30563885
[TBL] [Abstract][Full Text] [Related]
11. Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. ESPS Investigators. European Stroke Prevention Study.
Forbes CD
Thromb Res; 1998 Sep; 92(1 Suppl 1):S1-6. PubMed ID: 9781830
[TBL] [Abstract][Full Text] [Related]
12. Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study.
Chairangsarit P; Sithinamsuwan P; Niyasom S; Udommongkol C; Nidhinandana S; Suwantamee J
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S148-54. PubMed ID: 16858953
[TBL] [Abstract][Full Text] [Related]
13. Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
Hankey GJ; Eikelboom JW
Neurology; 2005 Apr; 64(7):1117-21. PubMed ID: 15824331
[TBL] [Abstract][Full Text] [Related]
14. [Secondary prevention with clopidogrel after TIA or stroke].
Zuurbier SM; Vermeer SE; Hilkens PH; Algra A; Roos YB
Ned Tijdschr Geneeskd; 2013; 157(25):A5836. PubMed ID: 23777963
[TBL] [Abstract][Full Text] [Related]
15. Comparative Efficacy and Safety of Nine Anti-Platelet Therapies for Patients with Ischemic Stroke or Transient Ischemic Attack: a Mixed Treatment Comparisons.
Huang HP; Lin WH; Chen SG; Chen LZ; Chen MY; Che CH
Mol Neurobiol; 2017 Mar; 54(2):1456-1466. PubMed ID: 26846361
[TBL] [Abstract][Full Text] [Related]
16. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
Overgaard K; Poulsen TS; Husted SE
Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
18. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Lancet; 2006 May; 367(9523):1665-73. PubMed ID: 16714187
[TBL] [Abstract][Full Text] [Related]
19. Emerging therapies: ESPRIT.
Moussouttas M
Stroke; 2007 Apr; 38(4):1142. PubMed ID: 17303765
[No Abstract] [Full Text] [Related]
20. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
Diener HC; Cunha L; Forbes C; Sivenius J; Smets P; Lowenthal A
J Neurol Sci; 1996 Nov; 143(1-2):1-13. PubMed ID: 8981292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
